This set of genes included cancer oncogenes (CMYC, CKIT, BCL2, KRAS) and genes associated with different cancer types (ADAM12, ALOX5, SRSF6, VEGF12) as well as FMR1, associated with fragile X syndrome (OMIM: 300624), and SNX12, which is associated with neurodegenerative diseases (Table S2). This evidence concerns the gene BCL2 and fragile X syndrome.